UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment

Canadian journal of gastroenterology, 2013-11, Vol.27 (11), p.653-659

2013

Volltextzugriff (PDF)

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Gastroenterology (New York, N.Y. 1943), 2023-09, Vol.165 (3), p.670-681

2023

Volltextzugriff (PDF)

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

Nature genetics, 2007-05, Vol.39 (5), p.596-604

2007

Volltextzugriff (PDF)

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

Journal of cutaneous medicine and surgery, 2019-01, Vol.23 (1), p.50-74

2019

Volltextzugriff (PDF)

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Gut, 2023-08, Vol.72 (8), p.1462-1471

2023

Volltextzugriff (PDF)

Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression

Clinical gastroenterology and hepatology, 2007, Vol.5 (1), p.103-110

2007

Volltextzugriff (PDF)

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Inflammatory bowel diseases, 2019-01, Vol.25 (1), p.1-13

2019

Volltextzugriff (PDF)

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

Journal of rheumatology, 2019-07, Vol.46 (7), p.751-754

2019

Volltextzugriff (PDF)

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2803-2812

2021

Volltextzugriff (PDF)

Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

Clinical gastroenterology and hepatology, 2024-09, Vol.22 (9), p.1889-1897.e12

2024

Volltextzugriff (PDF)

Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?

Gastroenterology (New York, N.Y. 1943), 2022-06, Vol.162 (7), p.1831-1832

2022

Volltextzugriff (PDF)

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

BMC medical genetics, 2020-10, Vol.21 (1), p.1-204, Article 204

2020

Volltextzugriff (PDF)

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 – Inflammatory bowel disease task force meeting

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.639-644

2011

Volltextzugriff (PDF)

Prediction of Treatment Response in Crohn’s Disease Patients Using Contrast Enhanced Ultrasound: A Pilot Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S643-S643

2017

Volltextzugriff (PDF)

Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S400-S401

2017

Volltextzugriff (PDF)

Characterizing the Post-Transfer Period Amongst Patients with Pediatric Onset IBD: The Impact of Academic vs. Community Adult Care on Emergent Health Resource Utilization

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S980-S980

2017

Volltextzugriff (PDF)

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2018-07, Vol.24 (8), p.1808-1814

2018

Volltextzugriff (PDF)

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Inflammatory bowel diseases, 2018-03, Vol.24 (4), p.669-670

Steinhart, A Hillary

2018

Volltextzugriff (PDF)

Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S784-S784

2017

Volltextzugriff (PDF)

Traditional corticosteroids for induction of remission in Crohn's disease

Cochrane database of systematic reviews, 2008-04 (2), p.CD006792

2008

Volltextzugriff (PDF)

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2022-11, Vol.163 (5), p.1364-1376.e10

2022

Volltextzugriff (PDF)

Microbiome Composition is Altered in Patients with IBD Independent of Endoscopic Activity

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S991-S991

2017

Volltextzugriff (PDF)

Microbial Composition in IBD May Influence Clinical Symptoms Independent of Endoscopic Activity

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S193-S194

2017

Volltextzugriff (PDF)

Oral budesonide for induction of remission in ulcerative colitis

Cochrane database of systematic reviews, 2015-10, Vol.2015 (10), p.CD007698

2015

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaUlcerative Colitis

ThemaYoung Adult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(237)

Publikationsform

Sprache

Englisch
(279)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 – Inflammatory bowel disease task force meeting

Prediction of Treatment Response in Crohn’s Disease Patients Using Contrast Enhanced Ultrasound: A Pilot Study

Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment

Characterizing the Post-Transfer Period Amongst Patients with Pediatric Onset IBD: The Impact of Academic vs. Community Adult Care on Emergent Health Resource Utilization

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score

Traditional corticosteroids for induction of remission in Crohn's disease

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Microbiome Composition is Altered in Patients with IBD Independent of Endoscopic Activity

Microbial Composition in IBD May Influence Clinical Symptoms Independent of Endoscopic Activity

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

Oral budesonide for induction of remission in ulcerative colitis

Aktive Filter

Suchergebnisse filtern